CAPSTONE NATIONAL PARTNERS

Lobbying for ATTERX BIOTHERAPEUTICS · Biotherapeutical development

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Wisconsin · House · Senate · $15,000.00 income · posted Jan 8, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

FY26 Appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem